Literature DB >> 22443308

Defining hyperandrogenaemia according to the free androgen index in Chinese women: a cross-sectional study.

Zehong Zhou1, Renmin Ni, Yu Hong, Yu Li, Yunhui Wang, Xiaomiao Zhao, Dongzi Yang.   

Abstract

OBJECTIVE(S): To determine the normative cut-off value for the free androgen index (FAI) among reproductive-age women in China.
DESIGN: Cross-sectional, population-based study.
SETTING: A multistage systematic cluster random sampling among 16 communities from two rural and two city regions. PATIENT(S): A total of 1526 women were randomly selected from a representative sample of 3009 women aged 20-45 years from the general population of southern China. Among these women, 444 subjects without known factors affecting androgen levels were selected as the reference group. INTERVENTION(S): Subjects underwent physical examination, blood tests of hormone and metabolic profiles, and ultrasound evaluations. MEASUREMENT OF THE MAIN OUTCOMES: The FAI was calculated according to the following equation: FAI = 100 × total testosterone (nmol/l)/sex hormone-binding globulin (nmol/l). The normative cut-off value of the FAI was computed based on the 5th-95th percentiles and K-means cluster analysis (K = 2).
RESULTS: A reference range of 0·7-6·4 of the FAI was indicated by the 5th and 95th percentiles. K-means cluster analysis identified 6·1 as the cut-off value for the FAI in the total population, which was close to the upper limit determined by the 95th percentile. Hyperandrogenic women present with elevated risk factors for metabolic disorders. The mean FAI values decreased with age among the total population, as evaluated by either K-means clustering or a percentile analysis. The FAI value was negatively correlated with age (r = -0·185, P < 0·0001) and positively correlated with body mass index after adjustment for age (r = 0·250, P < 0·0001).
CONCLUSION: A reference range of 0·7-6·4 FAI was indicated by the 5th and 95th percentiles among the reference group, which excluded the subjects with factors known to affect androgen levels; 6·1 was identified by the K-means cluster analysis as the cut-off value of the FAI for the general population. Hyperandrogenic women present with higher risks for metabolic disorders.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22443308     DOI: 10.1111/j.1365-2265.2012.04395.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population.

Authors:  Hasina Maredia; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Satupaitea Viali; Nicola L Hawley; Stephen T McGarvey
Journal:  Clin Biochem       Date:  2016-02-18       Impact factor: 3.281

2.  Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements.

Authors:  Yabo Yang; Miao Ding; Na Di; Ricardo Azziz; Dongzi Yang; Xiaomiao Zhao
Journal:  J Clin Lab Anal       Date:  2018-10-23       Impact factor: 2.352

Review 3.  Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report.

Authors:  Marta Sumińska; Klaudia Bogusz-Górna; Dominika Wegner; Marta Fichna
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

4.  Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients.

Authors:  Emanuele Garzia; Valentina Galiano; Giovanni Marfia; Stefania Navone; Enzo Grossi; Anna Maria Marconi
Journal:  Reprod Biol Endocrinol       Date:  2022-01-04       Impact factor: 5.211

5.  Effect of free androgen index on blood pressure variability and target organ damage in postmenopausal hypertensive women: findings from a cross-sectional study.

Authors:  Jianshu Chen; Qiongying Wang; Ying Pei; Ningyin Li; Junchen Han; Jing Yu
Journal:  Menopause       Date:  2021-08-23       Impact factor: 3.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.